We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
An Eli Lilly facility in Puerto Rico drew the FDA’s attention for manufacturing and quality deficiencies related to its breast cancer treatment abemaciclib. Read More
Impax Laboratories has sued the Federal Trade Commission for improperly deciding that it’s 2010 settlement with Endo Pharmaceuticals over Opana ER (oxycodone extended release) was anticompetitive. Read More
The U.S. Sixth Circuit Court of Appeals threw out Ohio Attorney General Dave Yost’s attempt to stop the Oct. 21 opioid bellwether trial of two Ohio counties against drugmakers and distributors. Read More
The FDA issued a complete response letter to Tanvex BioPharma for its proposed biosimilar for Amgen’s Neupogen (filgrastim) for the creation of white blood cells following chemotherapy. Read More
Johnson & Johnson said it will contest a Philadelphia jury’s decision to award $8 billion to a man who claimed its drug Risperdal (risperidone) caused him to grow breasts. Read More